Published in
Elsevier, Annals of Oncology, (30), p. v688, 2019
DOI: 10.1093/annonc/mdz283.010
Elsevier, European Journal of Cancer, (137), p. 1-9, 2020
DOI: 10.1016/j.ejca.2020.06.016
Links
Tools
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft tissue sarcomas who are not candidates for chemotherapy
Journal article published in 2019 by
Angela C. Hirbe 
,
M. Varun,
Brian A. Van Tine,
Vanessa Eulo,
Chang I. Moon,
Jingqin Luo ,
Stephanie Myles,
Mahesh Seetharam,
Jacqui Toeniskoetter,
Tammy Kershner,
Sasha Haarberg,
Mark Agulnik,
Varun Monga ,
Mohammad Milhem,
Amanda Parkes
and other authors.
,
M. Varun,
Brian A. Van Tine,
Vanessa Eulo,
Chang I. Moon,
Jingqin Luo ,
Stephanie Myles,
Mahesh Seetharam,
Jacqui Toeniskoetter,
Tammy Kershner,
Sasha Haarberg,
Mark Agulnik,
Varun Monga ,
Mohammad Milhem,
Amanda Parkes
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 